Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-1.61	71.43	72.60
Graham Fair Price	6.52	1.68	1.58
PEG	inf	0.00	-7.06
Price/Book	-13.74	5.37	6.22
Price/Cash Flow	-2.13	102.36	104.59
Prices/Earnings	-2.13	33.27	33.99
Price/Sales	-2.13	12.72	13.00
Price/FCF	-2.13	102.36	104.59
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.41	0.41
Operating Margin	0.00	0.14	0.14
ROA	0.00	0.03	0.03
ROE	0.05	0.04	-11.86
ROIC	0.05	0.04	-17.34
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.00	-1.00	inf
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	< 0.005	0.00	inf
EPS QOQ	-0.05	0.00	inf
FCF QOQ	0.12	0.00	inf
Revenue QOQ	0.02	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Not Interpreted

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.00	0.03	100.00
Quick Ratio	0.70	0.70	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.56	1.77	13.46
Cash	0.51	0.51	0.00
Capex	< 0.005	< 0.005	0.00
Free Cash Flow	0.09	0.09	0.00
Revenue	0.75	0.75	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.79	1.79	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-4.00	-3.53	11.59
Naive Interpretation	Member

06 - Financial Health · Weak

Rating